Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) -40.72-96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -40.72 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-40.72
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -40.72
Negative
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹360.4 Cr -4.8% -24.6% -33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,666.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 2.7% 0.4% 3.4% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-4.8%

-24.6%

-33.6%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses